Navigation Links
New antibiotic already developing resistance

An anti biotic, just a year old, which was developed to fight resistant bacteria, is already becoming stale as the bacteria are showing signs of resistance.

The drug linezolid is used to treat Enterococcus faecium (E. faecium) infections that are resistant to the old standby antibiotic vancomycin. The hope has been that the new drug would help tackle the growing problem of vancomycin-resistant enterococci infections. But in the April 14th issue of The Lancet, Chicago doctors report on five cases in which patients' infections became resistant to linezolid, as well.

Antibiotic resistance is a major problem worldwide, and hospitals are ground zero since infections and antibiotics are part of everyday life in these settings. Bacteria have an innate ability to mutate, and when they are repeatedly exposed to an antibiotic, they learn to change themselves in order to evade the drug. Bacteria that cause diseases such as pneumonia, tuberculosis and meningitis have learned to outsmart standard treatments. Without new drugs, experts fear some bacterial infections will become untreatable.

Before 1989, no US hospitals had experienced vancomycin-resistant E. faecium infections. By 1993, however, more than 10% of these infections acquired in hospitals were resistant to treatment. Linezolid was approved in April 2000 for the treatment of vancomycin-resistant E. faecium. Hence, doctors advice a sensitivity test before starting a patient on linezolid.
'"/>




Page: 1

Related medicine news :

1. Gene clue to antibiotics
2. Excessive use of antibiotics for sore throat
3. E. coli strains resistant to a common antibiotic
4. Cost-effective antibiotics for sinusitis treatment
5. Treatment of antibiotics ineffectual in bronchitis
6. Eczema patients lack natural antibiotic in skin
7. Modified antibiotic may support fight cancer
8. Vaccine Reduces antibiotic-resistant infections in Children
9. Use of antibiotics in farms may increase ‘super bugs
10. Frequent use of antibiotics raises the risk of carrying resistant infections
11. Novel antibiotic dressing developed for improved wound healing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/2/2016)... Dallas, Texas (PRWEB) , ... May 02, 2016 ... ... Volume 3, Issue 1 of Patient Experience Journal (PXJ), an international, open ... patient experience. With almost half the issue representing international (non-US) based authors, the ...
(Date:5/2/2016)... ... May 02, 2016 , ... Eating Recovery Center’s ... eating, mood and anxiety disorders, has rebranded its eating disorder program under a new ... eating disorder treatment facility on May 16. , To celebrate, ERC Chicago will ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... in Huntington Beach, California announced today the release of Grow Healthy Vending’s newly ... is one of the fastest growing healthy vending providers in North America with ...
(Date:5/2/2016)... ... ... This week Omega Institute, a premier nonprofit educational retreat center in New ... is offering a record 370 in-person workshops and new online learning opportunities and ... in or need for the knowledge and skills we’ve been cultivating for nearly 40 ...
(Date:5/2/2016)... ... ... World Ultimate & Guts Championship (WUGC) Mixed roster was announced in February and Chris Mazur, ... being held in London, England this year from June 18-25. At the last WUGC in ... the women’s masters division, and a silver in the women’s division, so Mazur hopes to ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016  Marking its ... accessible breast and ovarian cancer risk test, ... analyzing 30 genes that highly impact the most ... Available today, the Color Test analyzes hereditary cancer ... stomach, and uterine cancers. The Color Test is ...
(Date:4/28/2016)... , April 28, 2016 Dr. ... and Ste phen ... ArisGlobal®, a leading provider of cloud-based software solutions for life sciences, ... team to bring a wealth of insight to a growing business. ... knowledge. George Phillips joined ArisGlobal in the ...
(Date:4/28/2016)... 28, 2016 New market ... is a report that provides an overview of ... pipelines by identifying new targets and MOAs to ... Profiles discussed in this H1 2016 Osteoarthritis Pipeline ... AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios ...
Breaking Medicine Technology: